Holen Sie sich die Stockscreener-App
18.29
4.69%
0.82
Handel nachbörslich:
19.30
1.01
+5.52%
Schlusskurs vom Vortag:
$17.47
Offen:
$17.74
24-Stunden-Volumen:
552.91K
Relative Volume:
0.73
Marktkapitalisierung:
$2.02B
Einnahmen:
$461.26M
Nettoeinkommen (Verlust:
$-175.95M
KGV:
-11.38
EPS:
-1.607
Netto-Cashflow:
$-164.65M
1W Leistung:
-2.87%
1M Leistung:
-5.67%
6M Leistung:
-42.18%
1J Leistung:
-48.33%
1-Tages-Spanne:
$17.70
$18.38
1-Wochen-Bereich:
$17.33
$18.71
52-Wochen-Spanne:
$15.96
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Firmenname
Zai Lab Limited Adr
Sektor
Branche
Telefon
862161632588
Adresse
899 HALEI ROAD, SHANGHAI
Compare ZLAB vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
18.29 | 1.93B | 461.26M | -175.95M | -164.65M | -1.607 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Fortgesetzt | Jefferies | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-21 | Eingeleitet | Macquarie | Outperform |
| 2021-10-12 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-04-15 | Eingeleitet | Guggenheim | Buy |
| 2019-07-12 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-05 | Eingeleitet | Macquarie | Outperform |
| 2019-01-29 | Eingeleitet | Credit Suisse | Outperform |
| 2018-11-21 | Eingeleitet | Jefferies | Buy |
| 2018-06-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Eingeleitet | JP Morgan | Neutral |
| 2017-10-16 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
Richard Gaynor Acquires 1,731 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase - Stock Titan
Zai Lab AACR Update Puts Internal Oncology Pipeline And Global Aims In Focus - Sahm
Zai Lab (NASDAQ:ZLAB) Given New $32.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC) - ChartMill
Zai Lab (NASDAQ:ZLAB) CFO Sells $31,726.89 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Joshua Smiley Sells 1,966 Shares - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $55,088.91 in Stock - MarketBeat
Zai Lab (ZLAB) officer granted options, RSUs and sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CLO awarded major option, RSU grants and sells ADSs for taxes - Stock Titan
Zai Lab (NASDAQ: ZLAB) officer gets major equity grants, sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CEO receives large ADS option and RSU grants - Stock Titan
Assessing Zai Lab (ZLAB) Valuation After Prolonged Share Price Weakness And Reported Intrinsic Discount - Sahm
ZLAB (NASDAQ: ZLAB) notice: 1,281 ADS proposed sale on 03/13/2026 - Stock Titan
[144] Zai Lab Ltd SEC Filing - Stock Titan
Rafael Amado sells ZLAB ADS; 10,787 and 10,000 shares reported (ZLAB) - Stock Titan
Zai Lab Ltd (ADR) Stock (ISIN: CA98959U1084) Faces Insider Selling Pressure Amid Earnings Anticipati - AD HOC NEWS
[Form 4] Zai Lab Ltd Insider Trading Activity - Stock Titan
Zai Lab (NASDAQ: ZLAB) director files Form 144 to sell ADS - Stock Titan
Zai Lab (ZLAB) CEO exercises options and sells 100,000 ADS under 10b5-1 plan - Stock Titan
50,000 ADS sale flagged for ZLAB (NASDAQ: ZLAB) with recent Ying Du ADS sales - Stock Titan
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Zai Lab (ZLAB) CEO trades 100K ADS under 10b5-1 plan - Stock Titan
Zai Lab Ltd (ADR) (ZJM, ISIN CA98959U1084) under investor scrutiny as global biotech sentiment shift - AD HOC NEWS
Zai Lab (NASDAQ: ZLAB) insider sale: Ying Du reports 50,000 ADS transactions - Stock Titan
Zai Lab (ZLAB) officer sells 10,000 ADS under Rule 10b5-1 plan - Stock Titan
15,569 ADS proposed sale at ZLAB (ZLAB) and recent insider sale - Stock Titan
Zai Lab (NASDAQ:ZLAB) Shares Up 9.3%Should You Buy? - MarketBeat
Affiliate sale: ZLAB (NASDAQ: ZLAB) files to sell 10,000 ADS - Stock Titan
Cantor Fitzgerald Lowers Zai Lab (NASDAQ:ZLAB) Price Target to $37.00 - Defense World
Zai Lab Q4 Earnings Call Highlights - Yahoo Finance
Zai Lab Limited 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ZLAB) 2026-02-27 - Seeking Alpha
Zai Lab (NASDAQ:ZLAB) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Zai Lab Ltd SEC 10-K Report - TradingView
Zai Lab (NASDAQ: ZLAB; 9688) lifts 2025 revenue 15% and cuts loss - Stock Titan
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - ChartMill
An Overview of Zai Lab's Earnings - Sahm
Zai Lab (ZLAB) Expected to Announce Earnings on Thursday - MarketBeat
Zai Lab Stock Pops on U.S. FDA Progress: Is Wall Street Still Too Bearish? - AD HOC NEWS
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Here’s What Happened - Defense World
Qiming funds disclose 4.4% Zai Lab (ZLAB) stake in amended 13G/A - Stock Titan
Zai Lab (NASDAQ:ZLAB) Shares Gap UpHere's Why - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $51.59 Consensus Price Target from Analysts - Defense World
Constellation Software Inc. (OTCMKTS:CNSWF) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Analysts Set Kraken Robotics Inc. (CVE:PNG) PT at C$7.13 - Defense World
Brokerages Set Whirlpool Corporation (NYSE:WHR) Target Price at $85.43 - Defense World
Everus Construction Group, Inc. (NYSE:ECG) Receives $102.75 Average PT from Brokerages - Defense World
FY2026 Earnings Forecast for PACCAR Issued By Zacks Research - Defense World
Plexus Corp. (NASDAQ:PLXS) Receives $189.20 Average Target Price from Analysts - Defense World
Brokerages Set Adherex Technologies Inc. (NASDAQ:FENC) PT at $14.50 - Defense World
Finanzdaten der Zai Lab Limited Adr-Aktie (ZLAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):